At least 56 health facilities in 16 Mozambican districts are already administering injectable lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP), benefiting 15,700 people, the Ministry of Health told Lusa yesterday, adding that it intends to expand coverage. According to the information, lenacapavir to prevent Human Immunodeficiency Virus (HIV) infection…